Greg Guenthner

Biotech buyouts are coming. But no one’s paying attention…

New record highs for stocks are instead sparking refreshed arguments from economists and analysts alike. They want to debate peak valuations or whether or not we’re entering a “Goldilocks economy” where growth is not too hot, not too cold—but just right.

But all of the debate about how hot the economy will run for the rest of the year is distracting you from a couple of critical developments in the stock market.

The first (and potentially most important) trend you need to watch is the biotech comeback.

You know the drill…

Earlier this year, biotechs rocketed higher. The sector posted 30%-plus gains during the first eight weeks of the year. Almost every single day, a different biotech would easily rise double-digits. And while this was an active trader’s paradise, these stocks did end up getting a little ahead of themselves.

But now, we’re seeing a strong resurgence in the biotechs. In just a few weeks, these stocks have gone from losers back to winners. As of this morning, the biotech sector is up more than 12% on the year, compared to gains of just 5.5% in the S&P 500…

SPDR S&P Biotech Index vs. S&P 500

Now, the buyouts are back. Yesterday, a small-cap biotech called Idenix Pharmaceuticals (NASDAQ:IDIX) jumped by 229%. ‬

Yes, in one day…‬

How did this happen?

Well, pharmaceutical giant Merck agreed to pay $3.8 billion to acquire the company in full. Not only did Idenix stock shoot way up– almost every small to mid-size biotech stock went up because of the Merck – Idenix acquisition news.

Regards,

Greg Guenthner
for The Daily Reckoning

P.S. According to our own biotech expert Paul Mampilly, we should see more market-moving activity like this in the near future. I’ll be giving readers of my Rude Awakening email edition all the details – including regular chances at real, actionable profit opportunities – as the story progresses. So make sure you sign up for the Rude Awakening for FREE today to see how you can trade these trends for huge gains…

Greg Guenthner

Greg Guenthner, CMT, is the managing editor of The Rude Awakening. Greg is a member of the Market Technicians Association and holds the Chartered Market Technician designation.

Recent Articles

Boeing and SpaceX Fly Together

Stephen Petranek

Getting into space is getting more complex, and a lot cheaper. A recent launch typifies the new power of private rocketry as well as the ability of competitors like SpaceX and Boeing to cooperate to make the price tag of a launch cheaper. Stephen Petranek has more…


Forget Dinosaur Tech IPOs — Just Buy Apple

Greg Guenthner

Companies go public to rake in a few billion dollars for themselves and the underwriters. And the suckers-- sorry, investors who gobble up shares when these things come out-- usually end up losers. The stock sinks once the initial euphoria wears off. Then it levels off at a much lower price before maybe rising at a normal pace again.


Beware the Money Illusion Coming to Destroy Your Wealth

James Rickards

A money illusion sounds like something a prestidigitator performs by pulling $100 bills from a hat shown to be empty moments before. In fact, money illusion is a longstanding concept in economics that has enormous significance for you if you’re a saver, investor or entrepreneur. Jim Rickards explains...


Low Oil Prices Are A Saudi Attack On Iran — But You Can Defend Yourself

Byron King

Traders bid up oil prices this week, based on reports of major escalation of hostilities in Yemen, just south of Saudi Arabia. It’s part of Iran’s long-term strategy to surround the Saudis. Which is why Byron says the Saudis’ primary motivation in crashing oil prices last November was to weaken Iran...